Kbc Group Nv Roivant Sciences Ltd. Transaction History
Kbc Group Nv
- $36.3 Billion
- Q4 2024
A detailed history of Kbc Group Nv transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Kbc Group Nv holds 15,874 shares of ROIV stock, worth $172,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,874
Previous 10,035
58.19%
Holding current value
$172,074
Previous $116,000
62.07%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
319Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$715 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$713 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$586 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$452 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$383 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.64B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...